HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
Section

Policy

IRA, state PBM reform, Medicare, and regulatory action

Federal appeals court blocks mailing of abortion pill mifepristone
PolicySTAT News ↗
Mifepristone, involved in most abortions in the U.S., can now be distributed only in person and at clinics.…
May 2, 2026
Purdue Pharma’s Dissolution Approved, Closing Chapter in OxyContin Legal Case
PolicyBriefing
A judge approved Purdue Pharma’s criminal sentence, clearing the way for the company’s dissolution after years…
May 1, 2026
PolicyAJMC ↗
Apr 30, 2026
House panel calls to ban China data from FDA drug trial applications
PolicyEndpoints News ↗
A powerful spending committee in Congress wants the FDA to ban the use of clinical trial data from China in fu…
Apr 30, 2026
Supreme Court questions how far generics makers can go with 'skinny label' drugs
PolicyEndpoints News ↗
WASHINGTON — Supreme Court justices gave a few hints about how they intend to rule in a divisive case for the …
Apr 30, 2026
STAT+: FDA wants to exclude weight loss drugs from a compounding list
PolicySTAT News ↗
FDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, saying there's n…
Apr 30, 2026
← Newer Page 9 Older →
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.